,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,449703,5,2,,103713284,13076,Active,,,0.8029999999999999,EC50,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay,Confirmatory,18579783.0,
1,449704,5,2,,103713284,13076,Active,,,0.8270000000000001,EC50,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay,Confirmatory,18579783.0,
2,449705,5,2,,103713284,13076,Active,,,21.61,CC50,NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7),Confirmatory,18579783.0,
3,449706,5,2,,103713284,13076,Unspecified,,,,,"NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.",Other,18579783.0,
4,602156,1,1,,131335200,13076,Inactive,,,,IC50,Novartis GNF Liver Stage Dataset: Malariabox Annotation,Other,22096101.0,
5,603957,1,3,,103713284,13076,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,17629592.0,
6,1259407,1,1,,363900692,13076,Inactive,,,,,CCRIS mutagenicity studies,Other,,
7,1259408,1,1,,363895890,13076,Active,,,,,GENE-TOX mutagenicity studies,Other,,
